Evidence map›Paper›PMID 34360536›Full record

ReviewInternational journal of molecular sciences2021

Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics.

Qingliang Yang, Harshani Wijerathne, Jordan C Langston, Mohammad F Kiani, Laurie E Kilpatrick

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Blood-Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Advances in Endothelial Cell Biology: From Knowledge to Control.International journal of molecular sciences · 2022
    Article
  15. Omics of endothelial cell dysfunction in sepsis.Vascular biology (Bristol, England) · 2022
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qingliang YangDepartment of Mechanical Engineering, Temple University, Philadelphia, PA 19122, USA.
Harshani WijerathneDepartment of Chemistry, University of Kansas, Lawrence, KS 66045, USA.
Jordan C LangstonDepartment of Bioengineering, Temple University, Philadelphia, PA 19122, USA.
Mohammad F KianiDepartment of Mechanical Engineering, Temple University, Philadelphia, PA 19122, USA.
Laurie E KilpatrickCenter for Inflammation, Clinical and Translational Lung Research, Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0002-2554-507X

Funding

Leukocyte-Endothelial Cell Interactions in SepsisR01GM114359 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI KIANI, MOHAMMAD F, KILPATRICK, LAURIE E · 2015 to 2018
$1.2M
Integrating microfluidic, omic, and in silico models to screen therapeutics for sepsisR01GM134701 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI KIANI, MOHAMMAD F, KILPATRICK, LAURIE E · 2019 to 2020
$656k
Defense Threat Reduction Agency HDTRA11910012NIGMS NIH HHS R01 GM114359NIGMS NIH HHS R01 GM134701NIH HHS GM114359NIH HHS GM134701
6 · The paper itself

Abstract

The endothelium is the inner layer of all blood vessels and it regulates hemostasis. It also plays an active role in the regulation of the systemic inflammatory response. Systemic inflammatory disease often results in alterations in vascular endothelium barrier function, increased permeability, excessive leukocyte trafficking, and reactive oxygen species production, leading to organ damage. Therapeutics targeting endothelium inflammation are urgently needed, but strong concerns regarding the level of phenotypic heterogeneity of microvascular endothelial cells between different organs and species have been expressed. Microvascular endothelial cell heterogeneity in different organs and organ-specific variations in endothelial cell structure and function are regulated by intrinsic signals that are differentially expressed across organs and species; a result of this is that neutrophil recruitment to discrete organs may be regulated differently. In this review, we will discuss the morphological and functional variations in differently originated microvascular endothelia and discuss how these variances affect systemic function in response to inflammation. We will review emerging in vivo and in vitro models and techniques, including microphysiological devices, proteomics, and RNA sequencing used to study the cellular and molecular heterogeneity of endothelia from different organs. A better understanding of microvascular endothelial cell heterogeneity will provide a roadmap for developing novel therapeutics to target the endothelium.

Indexed as

AnimalsAnti-Inflammatory AgentsEndothelium, VascularHumansInflammationAnti-Inflammatory AgentsbMFAendothelial barrier permeabilityheterogeneityinflammationleukocytesmicrophysiological systemsmicrovascular endothelial cellsprotein kinase Cδsepsistransmigration

Identifiers

PMID34360536
PMCPMC8346165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.